Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 5M P/E - EPS this Y - Ern Qtrly Grth -
Income -5.9M Forward P/E -2.10 EPS next Y 37.90% 50D Avg Chg -25.00%
Sales 53.95k PEG - EPS past 5Y - 200D Avg Chg -20.00%
Dividend N/A Price/Book 4.27 EPS next 5Y - 52W High Chg -74.00%
Recommedations 2.00 Quick Ratio 0.86 Shares Outstanding 10.04M 52W Low Chg 61.00%
Insider Own 10.14% ROA -115.33% Shares Float 7.55M Beta 0.44
Inst Own 3.28% ROE -714.18% Shares Shorted/Prior 279.82K/230.88K Price 0.61
Gross Margin -51.53% Profit Margin - Avg. Volume 1,269,870 Target Price 1.25
Oper. Margin -10,350.57% Earnings Date - Volume 74,640 Change 0.07%
About Aclarion, Inc.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Aclarion, Inc. News
11/21/24 Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
11/14/24 Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
10/10/24 Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
09/27/24 Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
09/13/24 PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
09/12/24 Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
09/11/24 Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
09/10/24 Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
09/06/24 Aclarion Added to PRISM Emerging Medical Devices Index
09/05/24 Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market
08/29/24 Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
08/21/24 Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
08/17/24 Aclarion Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
08/15/24 Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
08/14/24 Aclarion Announces First Commercial Agreement in Michigan
08/13/24 Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK
07/09/24 Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
06/26/24 Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
06/25/24 Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
06/20/24 Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
ACON Chatroom

User Image investimakerrr Posted - 2 days ago

$ACON there should be a quick p& d soon here

User Image BigGreenCandle Posted - 3 days ago

$ACON Is there a glitch in the matrix here? Micro float with a decent average volume, a bit of news, and here we sit...

User Image BigGreenCandle Posted - 4 days ago

$ACON Micro float and heading down. Took a nibbler and getting out under .16 but does it have any room left for another pump?

User Image Bossroalkvam Posted - 4 days ago

$ACON https://www.linkedin.com/posts/aclarion_congratulations-to-kris-radcliff-md-at-the-activity-7265034337849352194-p_5v?utm_source=share&utm_medium=member_ios

User Image PeteRePete Posted - 6 days ago

$ACON very close

User Image Jerseyguy856 Posted - 6 days ago

$ACON big bid

User Image TurskaInTar Posted - 1 week ago

$ACON Got stopped out at 0.1818 a while ago, but still holding some because anything can happen. Waiting and watching some time to buy back more. Still

User Image Bullish06 Posted - 1 week ago

$AUUD Auddia to Present at the Virtual Investor Summit Microcap Event on November 21st https://www.reddit.com/r/Auddia/s/ME4Lw4hXIg $ACON idk maybe another run $NVDA = 170+ next week $DOGE.X .90

User Image GFXS22 Posted - 1 week ago

$ACON Earnings pre market 11/26 Projected -.17 Improvement from last earnings.

User Image Number_03 Posted - 1 week ago

@Jov_Bon what does this news have to do with $ACON?

User Image Bullish06 Posted - 2 weeks ago

$ACON runup before RS

User Image Number_03 Posted - 2 weeks ago

$WBUY next is $ACON be ready for it

User Image TradesCrusher Posted - 2 weeks ago

$ACON

User Image JasonCO Posted - 2 weeks ago

$ACON no

User Image RollingDollars Posted - 2 weeks ago

$ACON

User Image Bossroalkvam Posted - 2 weeks ago

$ACON New from sec💪🏼 3 months extension Now let’s have some good news ✨👌 We had an appeal hearing on October 10, 2024 before the Panel to appeal the delisting notices from the Staff. The Panel has granted the Company an extension until January 31, 2025 to demonstrate compliance with the Bid Price Requirement and the Stockholders' Equity Requirement. As noted above, we plan to implement a reverse stock split in the near future in order to assist with the Company’s compliance with Nasdaq’s Bid Price Requirement. The Company also is working to demonstrate compliance with the Stockholders' Equity Requirement as requested by the Panel. While the appeal process is pending, the suspension of trading of the Company’s common stock will be stayed. Our common stock will continue to trade on Nasdaq until the hearing process concludes and the Panel issues its final written determination. https://www.sec.gov/Archives/edgar/data/1635077/000168316824007604/aclarion_424b3-froms1.htm

User Image ASTANA Posted - 2 weeks ago

$ACON $NVDA ,🎉🎉🎉

User Image Bossroalkvam Posted - 2 weeks ago

$ACON The Panel has granted the Company an extension until November 21, 2024 to demonstrate compliance with the Bid Price Requirement and the Stockholders' Equity Requirement. As noted above, we plan to implement a reverse stock split in the near future in order to assist with the Company’s compliance with Nasdaq’s Bid Price Requirement. The Company also is working to demonstrate compliance with the Stockholders' Equity Requirement as requested by the Panel. While the appeal process is pending, the suspension of trading of the Company’s common stock will be stayed. Our common stock will continue to trade on Nasdaq until the hearing process concludes and the Panel issues its final written determination. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001635077/000168316824007558/aclarion_resale-s3.htm

User Image Bossroalkvam Posted - 3 weeks ago

$ACON You see a clear manipulation. Add and drop. The ordinary sales is 0.2041 Holding!!

User Image Bossroalkvam Posted - 3 weeks ago

$ACON Tons of great news,and this is how it’s treated Holding!! September 27, 2024 Aclarion’s Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes September 12, 2024 Aclarion Provides Corporate Update on Nociscan AI Technology Milestones September 10, 2024 Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial September 5, 2024 Aclarion Launches Surgeon Partnership in Personal Injury and Workers Compensation Market August 29, 2024 Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

User Image Bossroalkvam Posted - 3 weeks ago

$ACON Some ideas where it’s going today ? 150.000 shares borrowed/shorted before opening. Maybe a squeeze is possible? I guess the manipulators involved will tell you at opening. Holding 💪🏼 https://chartexchange.com/symbol/nasdaq-acon/borrow-fee/

User Image Bossroalkvam Posted - 10/31/24

$ACON And I guess it’s because of all the bad news that dropped today😇 Well holding my position

User Image Bossroalkvam Posted - 10/31/24

$ACON Manipulation time again

User Image Bossroalkvam Posted - 10/31/24

$ACON Holding

User Image TurskaInTar Posted - 10/29/24

$ACON Fighting strong with low volume 💪 Closing price/MA's looking better again

User Image Bossroalkvam Posted - 10/28/24

$ACON Added

User Image garygb Posted - 10/26/24

$ACON Dropped too much. Hurry.

User Image TurskaInTar Posted - 10/26/24

$ACON Nothing new much, it was known they need to solve the compliance issue somehow and need cash. But waiting with interest how the minimun bid price issue will work out, because the Panel hasn't given their decision, it might also be an extension and no R/S needed. If they are granted the extension, then there must be some good catalyst coming up that has convinced the panel.

User Image Bossroalkvam Posted - 10/25/24

$ACON Latest sec news. Bullish!!! https://www.sec.gov/ix?doc=/Archives/edgar/data/0001635077/000168316824007397/aclarion_s1.htm While the appeal process is pending, the suspension of trading of the Company’s common stock will be stayed. Our common stock will continue to trade on Nasdaq until the hearing process concludes and the Panel issues a written decision. The Company intends to take all reasonable measures available to regain compliance under the Nasdaq Listing Rules and remain listed on Nasdaq. The Company is currently evaluating its available options to resolve the deficiency and regain compliance with the Stockholders’ Equity Requirement. The Company’s receipt of these letters from Nasdaq does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

User Image TurskaInTar Posted - 10/25/24

$ACON Basic Friday action, no fear. Look at the facts, the things going on and the MARKET CAP.

Analyst Ratings
Ascendiant Capital Buy Aug 26, 24
Ascendiant Capital Buy Jul 29, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Ness Brent Chief Executive Offi.. Chief Executive Officer Dec 28 Buy 0.5 18,500 9,250 19,500 12/29/22
Lorbiecki John Paul Chief Financial Offi.. Chief Financial Officer Dec 29 Buy 0.44 22,404 9,858 22,404 12/29/22
Bond Ryan Chief Strategy Offic.. Chief Strategy Officer Apr 22 Buy 2.80 20,000 56,000 20,000 04/25/22
Wesemann William Director Director Apr 21 Buy 4.35 11,000 47,850 52,736 04/25/22
Ness Brent Chief Executive Offi.. Chief Executive Officer Apr 21 Buy 4.35 1,000 4,350 1,000 04/25/22
Neal David K Director Director Apr 21 Buy 4.35 34,400 149,640 34,400 04/25/22